- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT05879354
Active Cycle of Breathing Techniques on Respiratory Distress Symptom Cluster
May 25, 2023 updated by: Doğa Ulcay, Maltepe University
Investigation of the Effect of Active Cycle of Breathing Techniques on Respiratory Distress Symptom Cluster in Patients With Lung Cancer
This study was designed as a randomized, control group, experimental study to examine the effect of Active Cycle of Breathing Techniques application on respiratory distress symptom cluster in patients with lung cancer.
Study Overview
Status
Not yet recruiting
Conditions
Intervention / Treatment
Detailed Description
The sample of the study will consist of patients who received chemotherapy treatment with the diagnosis of Stage IV non-small cell lung cancer in the outpatient chemotherapy service of a training and research hospital and met the inclusion criteria.
Data in the study will be collected using the Patient Information Form, Eastern Cooperative Oncology Group (ECOG) Performance Scale, Cancer Dyspnea Scale, Leicester Cough Questionnaire and Cancer Fatigue Scale.
In order to test the applicability and comprehensibility of the forms to be used before the study, a preliminary application will be made with 5 patients.
This study is planned to prepare a video describing the application for patients to use while performing the Active Cycle of Breathing Techniques application.
On the 1st day of the study, a 10-minute face-to-face training will be given to the intervention (experimental) group by the researcher using the video about the Active Cycle of Breathing Techniques.
In the research, the intervention (experimental) group will be asked to follow the video to be prepared and apply the Active Cycle of Breathing Techniques twice a day for 28 days.
The intervention (experimental) group will be monitored by telephone call once a week and 3 times using the Patient Follow-up Form (days 7, 14 and 21).
On the other hand, only the pre-test and post-test will be applied to the control group.
Study Type
Interventional
Enrollment (Estimated)
78
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Contact
- Name: Doğa Ulcay, Msc
- Phone Number: +905302285038
- Email: dogaulcay@maltepe.edu.tr
Study Contact Backup
- Name: Semiha Akın, Prof.
- Phone Number: +902167779317
- Email: semihaakin@sbu.edu.tr
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
- Adult
- Older Adult
Accepts Healthy Volunteers
No
Description
Inclusion Criteria:
- Being 18 years or older
- Being diagnosed with stage IV non-small cell lung cancer
- Being diagnosed with lung cancer in the type of adenocarcinoma and squamous cell carcinoma
- Receiving outpatient chemotherapy treatment
- Receiving the first course of chemotherapy treatment
- ECOG Performance Scale Score < 3
- Having all the symptoms of dyspnea, cough, and fatigue
- Not having a cognitive disorder or a diagnosed psychiatric illness
- Being able to speak Turkish
- Volunteering to participate in the research
Exclusion Criteria:
- Experiencing a chronic obstructive pulmonary disease (COPD) exacerbation in the last 4 weeks
- Having an active lung infection
- Not volunteering to participate in the research
- Not having dyspnea, cough, and fatigue symptoms
- Not speaking Turkish
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Supportive Care
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: Active Cycle Of Breathing Techniques Group
Patients in the intervention group will be provided with video-guided Active Cycle of Breathing Techniques twice a day for 28 days.
|
Patients in the intervention group will be provided with video-guided Active Cycle of Breathing Techniques twice a day for 28 days.
|
No Intervention: Control group
No intervention will be given to the patients in the control group.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Dyspnea Level
Time Frame: 28 Days
|
The level of dyspnea will be lower in patients in the intervention (experimental) group to whom Active Breathing Cycle techniques were applied, compared to the patients in the control group who did not.
The Turkish version of the Cancer Dyspnea Scale, the Turkish Validity and Reliability of which was made by Bitek and Tokem in 2021, will be used to measure the level of dyspnea.
|
28 Days
|
Fatigue Level
Time Frame: 28 days
|
The level of fatigue will be lower in patients in the intervention (experimental) group to whom Active Breathing Cycle techniques were applied, compared to the patients in the control group who did not.
The Turkish version of the Hirai Cancer Fatigue Scale, the Turkish validity and reliability of which was made by Mencel in 2021, will be used to measure the level of fatigue.
|
28 days
|
Health-related quality of life in chronic cough
Time Frame: 28 days
|
The level of health-related quality of life in chronic cough will be lower in patients in the intervention (experimental) group to whom Active Breathing Cycle techniques were applied, compared to the patients in the control group who did not.
The Turkish version of the Leicester Cough Questionnaire (LCQ), the Turkish validity and reliability of which was made by Gonen ve Havlucu in 2014, will be used to measure the level of health-related quality of life in chronic cough.
|
28 days
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Collaborators
Investigators
- Principal Investigator: Doğa Ulcay, Msc, Maltepe University
- Principal Investigator: Semiha Akın, Prof., University of Health science
- Principal Investigator: Akın Öztürk, Specialist, Sureyyapasa Chest Diseases and Thoracic Surgery Training and Research Hospital
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Estimated)
June 10, 2023
Primary Completion (Estimated)
May 30, 2024
Study Completion (Estimated)
May 30, 2024
Study Registration Dates
First Submitted
April 13, 2023
First Submitted That Met QC Criteria
May 25, 2023
First Posted (Actual)
May 30, 2023
Study Record Updates
Last Update Posted (Actual)
May 30, 2023
Last Update Submitted That Met QC Criteria
May 25, 2023
Last Verified
May 1, 2023
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- MAU_DogaUlcay_001
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Lung Neoplasms
-
UNC Lineberger Comprehensive Cancer CenterSivan Innovation Ltd.CompletedLung Cancer | Neoplasms, Lung | Pulmonary Neoplasms | Neoplasms, Pulmonary | Pulmonary Cancer | Cancer of LungUnited States
-
Baptist Health South FloridaWithdrawnLung Cancer | Lung TumorUnited States
-
Portsmouth Hospitals NHS TrustCompletedLung Cancer | Interstitial Lung DiseaseUnited Kingdom
-
Point TherapeuticsTerminatedCarcinoma, Non-Small-Cell Lung | Lung Cancer | Neoplasms, Lung | Neoplasms, PulmonaryUnited States
-
Oliver JonasMassachusetts General HospitalCompletedLung Cancer | Lung TumorUnited States
-
C. R. BardCompleted
-
University of UtahRecruitingLung Cancer | Lung Neoplasms/DiagnosisUnited States
-
Alliance for Clinical Trials in OncologyNational Cancer Institute (NCI)CompletedLung Carcinoma | Lung Neoplasm | Malignant Lung NeoplasmUnited States
-
Keimyung University Dongsan Medical CenterCompletedLung Cancer | Lung Diseases, Interstitial
-
Azienda Sanitaria-Universitaria Integrata di UdineRecruitingLung Diseases | Lung Cancer | Lung Adenocarcinoma | Lung Transplant Rejection | Lung; Node | Lung TBItaly
Clinical Trials on Active Cycle of Breathing Techniques
-
University of UlsterCompletedBronchiectasisUnited Kingdom
-
Marmara UniversityCompleted
-
Riphah International UniversityCompletedChronic Obstructive Pulmonary DiseasePakistan
-
Riphah International UniversityCompletedChronic Obstructive Pulmonary DiseasePakistan
-
Royal Brompton & Harefield NHS Foundation TrustNational Institute for Health Research, United KingdomCompleted
-
Riphah International UniversityRecruitingBreathing ExercisesPakistan
-
Superior UniversityRecruiting
-
Riphah International UniversityRecruiting
-
Riphah International UniversityCompletedShortness of BreathPakistan
-
Riphah International UniversityCompletedChronic Obstructive Pulmonary DiseasePakistan